Form 4: Director Gregg Williams Acquires Vivani Medical Stock Options

Director Gregg Williams of Vivani Medical, Inc. has acquired stock options as part of an annual grant under the company's Non-Employee Director Compensation Policy.

Summary

• Director Gregg Williams received an annual grant of non-qualified stock options for 36,516 shares of Vivani Medical, Inc. common stock.
• The exercise price for these options is $1.22 per share.
• The options were granted on June 24, 2026, and are exercisable starting June 23, 2036.
• These options vest in total on the earlier of the first anniversary of the grant date or the next annual stockholder meeting, contingent upon continued service.
• Gregg Williams is a Director and a 10% owner of Vivani Medical, Inc.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a standard compensation event for a director and does not provide new financial performance data or strategic updates.

Positives

• Director compensation aligns with company stock performance through options.
• The grant structure incentivizes continued service and long-term commitment from directors.

Negatives

• The filing does not contain financial performance data, making it difficult to assess the company's overall health.
• The value of the stock options is contingent on future stock price appreciation.

Risks

• The value of the stock options is subject to market volatility and the company's future performance.
• Vesting is contingent on continued service, meaning a director's departure before vesting would result in forfeiture of the options.

Future Outlook

The future outlook for the stock options is dependent on the company's stock performance and the director's continued service through the vesting period.

Industry Context

StockSavvy.ai notes that the issuance of stock options to directors is a common practice in the biotechnology and medical device sectors, aligning executive and director interests with those of shareholders. This filing is standard for reporting such grants.

Corporate Governance

Stakeholder Impact

• Shareholders: The grant of options aligns director incentives with shareholder value creation, but also dilutes ownership if exercised.
• Employees: This filing does not directly impact employees but reflects the company's compensation strategy.
• Management: The filing is a routine disclosure related to director compensation.

Next Steps

• Director Gregg Williams will continue to serve the company, working towards the vesting of his stock options.
• The company's stock performance will determine the ultimate value of the granted options.

Key Dates

Keywords

Form 4, Stock Options, Director Compensation, Vivani Medical, VANI, Beneficial Ownership, SEC Filing, Insider Trading